MedPath

Postpartum pElvic Assisted Recovery With Leva

Not Applicable
Not yet recruiting
Conditions
Postpartum Pelvic Floor Function and Symptoms
Interventions
Device: Digital therapeutic motion-based device
Registration Number
NCT06609317
Lead Sponsor
University of South Florida
Brief Summary

The goal of this prospective cohort study is to evaluate the feasibility of postpartum pelvic floor muscle training using an FDA-cleared digital therapeutic motion-based device.

In addition to assessing feasibility, investigators also will evaluate bladder and bowel function, pelvic organ prolapse symptoms, and vaginal and perineal pain in the immediate postpartum period and at 3 and 6 months postpartum. Investigators also will assess sexual function at 3 and 6 months postpartum.

Participants will use the motion-based device for postpartum pelvic floor muscle training and will complete electronically administered surveys at 3 and 6 months postpartum.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
25
Inclusion Criteria
  • Spontaneous vaginal delivery within the last 4-8 weeks
  • Age ≥ 18 years
  • Ambulatory
  • Willing and able to consent to participate.
  • English speaking
  • Owns a smartphone
Exclusion Criteria
  • Operative or cesarean delivery
  • Obstetric delivery at less than 20 weeks gestation
  • Third- or fourth-degree perineal laceration
  • Episiotomy
  • Multiples

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Device ArmDigital therapeutic motion-based deviceParticipants in this arm will use a digital therapeutic motion-based device for postpartum pelvic floor muscle training
Primary Outcome Measures
NameTimeMethod
FeasibilityFrom enrollment to 6 months postpartum

Feasibility will be assessed using participant reported discomfort with device use, ease of device use, net promotor score, patient satisfaction, and free text feedback on the device.

Perineal PainFrom enrollment to 6 months postpartum

Participants will complete validated surveys assessing perineal pain at baseline, 3 months postpartum, and 6 months postpartum.

Secondary Outcome Measures
NameTimeMethod
Bladder functionFrom enrollment to 6 months postpartum

Participants will complete validated surveys assessing bladder function at baseline, 3 months postpartum, and 6 months postpartum.

Bowel FunctionFrom enrollment to 6 months postpartum

Participants will complete validated surveys assessing bowel function at baseline, 3 months postpartum, and 6 months postpartum.

Pelvic Organ ProlapseFrom enrollment to 6 months postpartum

Participants will complete validated surveys assessing pelvic organ prolapse symptoms at baseline, 3 months postpartum, and 6 months postpartum.

Vaginal painFrom enrollment to 6 months postpartum

Participants will complete validated surveys assessing vaginal pain at baseline, 3 months postpartum, and 6 months postpartum.

Sexual functionFrom enrollment to 6 months postpartum

Participants will complete validated surveys assessing sexual function at 3 months postpartum and 6 months postpartum.

© Copyright 2025. All Rights Reserved by MedPath